Friday, 20 Feb 2026
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA
logo logo
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
  • 🔥
  • Trump
  • House
  • ScienceAlert
  • VIDEO
  • White
  • man
  • Trumps
  • Watch
  • Season
  • Years
Font ResizerAa
American FocusAmerican Focus
Search
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
Follow US
© 2024 americanfocus.online – All Rights Reserved.
American Focus > Blog > Economy > Analysts See 12% Upside To Thermo Fisher Scientific Inc. (TMO)
Economy

Analysts See 12% Upside To Thermo Fisher Scientific Inc. (TMO)

Last updated: December 21, 2025 4:40 am
Share
Analysts See 12% Upside To Thermo Fisher Scientific Inc. (TMO)
SHARE

Thermo Fisher Scientific Inc. (NYSE:TMO) has been identified as one of the 14 Best S&P 500 Stocks to Buy Now by Wall Street analysts. With a consensus Strong Buy rating and a one-year average share price target of $640.30, analysts see a potential upside of 12% for the stock.

Recent updates from analysts have further bolstered confidence in Thermo Fisher Scientific Inc. Wells Fargo raised its price target on the stock to $675 from $635, citing a clearer outlook on government policies impacting the pharmaceutical industry and promising future growth prospects. The firm maintains an Overweight rating on the stock, emphasizing the favorable conditions for companies in the tools and equipment sector.

Similarly, Citigroup upgraded Thermo Fisher Scientific Inc.’s rating to Buy from Neutral and increased its price target to $660 from $580. Analyst Patrick Donnelly highlighted the company’s position within the tools and diagnostics segment, anticipating benefits from onshoring trends and increased pharmaceutical spending.

Thermo Fisher Scientific Inc. is a prominent provider of life sciences solutions, laboratory products, diagnostics, analytical instruments, and biopharma services. Despite modest returns of 8% year-to-date in 2025, the stock continues to attract investor attention for its growth potential.

While Thermo Fisher Scientific Inc. presents a compelling investment opportunity, some analysts suggest exploring alternative options in the AI sector for greater upside potential and lower downside risk. For those interested in undervalued AI stocks poised to benefit from current economic trends, a free report on the best short-term AI stock is available.

In conclusion, Thermo Fisher Scientific Inc. remains a strong contender in the market, backed by positive analyst sentiment and a solid track record in the life sciences industry. Investors looking for diversified opportunities may consider exploring AI stocks for additional growth prospects.

See also  ExxonMobil’s 2025 Climate Report Fails Scientific Review—Again 

For more insights on stock opportunities, check out the 11 Most Oversold S&P 500 Stocks Heading into 2026 and the Top 15 Lowest P/E Ratios of the S&P 500 in 2025.

Disclosure: None.

TAGGED:analystsFisherscientificThermoTMOupside
Share This Article
Twitter Email Copy Link Print
Previous Article 10 Mind-Blowing Brain Discoveries from 2025 10 Mind-Blowing Brain Discoveries from 2025
Next Article Andre Reed Says It Could Finally Be Bills’ Year W/ Kansas City Out Of Playoffs Andre Reed Says It Could Finally Be Bills’ Year W/ Kansas City Out Of Playoffs
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular Posts

Hockey Player Janne Puhakka Dead At 29, Cops Believe Partner Behind Killing

Former hockey pro Janne Puhakka, Finland's first openly gay player, was tragically found shot to…

October 14, 2024

Dem senator slams ‘healthcare industry that mostly doesn’t give a s–t,’ urges lawmakers to listen to ‘visceral anger’ after Luigi Mangione accused of executing UnitedHealthcare CEO

Senator Chris Murphy, a Democrat, strongly criticized the health care industry for its lack of…

December 16, 2024

Nobel prize for medicine goes to trio for work on immune tolerance

Health The 2025 Nobel Prize in Physiology or Medicine has been awarded to Mary Brunkow,…

October 6, 2025

Menopause Matters: Addressing Knowledge Gaps And Stigma

UNITED STATES - MAY 2: Halle Berry speaks during a news conference on bipartisan legislation…

September 29, 2025

SAG-AFTRA Signs Podcast Agreement With Netflix

Netflix recently launched a new show called "The Pete Davidson Show," which has been described…

February 12, 2026

You Might Also Like

Vestwell Raises 5M in Funding, Doubling Total Investments
Economy

Vestwell Raises $385M in Funding, Doubling Total Investments

February 20, 2026
Trump Policy Reversal Sparks  Billion Dollar Bleed in EV Sector
Economy

Trump Policy Reversal Sparks $65 Billion Dollar Bleed in EV Sector

February 20, 2026
Trump’s order to release evidence for aliens obscures the scientific search for extraterrestrial life
Tech and Science

Trump’s order to release evidence for aliens obscures the scientific search for extraterrestrial life

February 20, 2026
Klarna Stock Is Deeply Oversold After Ugly Earnings Plunge. Should You Buy the Dip in KLAR Here?
Economy

Klarna Stock Is Deeply Oversold After Ugly Earnings Plunge. Should You Buy the Dip in KLAR Here?

February 20, 2026
logo logo
Facebook Twitter Youtube

About US


Explore global affairs, political insights, and linguistic origins. Stay informed with our comprehensive coverage of world news, politics, and Lifestyle.

Top Categories
  • Crime
  • Environment
  • Sports
  • Tech and Science
Usefull Links
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA

© 2024 americanfocus.online –  All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?